Erudio Healtherudio.com
Clinical trial · no report yet · Phase 2
SARC046
SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma
- NCT07104331 ↗
- Recruiting
- Sarcoma Alliance for Research through Collaboration
- Focused
We haven't built an HCP commentary report on SARC046 (nab-Sirolimus in Epithelioid Hemangioendothelioma (EHE)) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on SARC046 so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 2 | |
| YouTube | 1 |
The trial
ClinicalTrials.gov- Official title
- SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma
- Phase
- Phase 2
- Status
- Recruiting
- Conditions
- Epithelioid Hemangioendothelioma (EHE)
- Interventions
- nab-Sirolimus
- Arms
- non-randomized, open label, single arm · Experimental
- Enrollment
- 41 (estimated)
- Primary outcomes
- Tumor response rate
- Sponsor
- Sarcoma Alliance for Research through Collaboration
- Start
- Feb 24, 2026
- Primary completion
- Aug 30, 2029 (estimated)
- Results posted
- No
- Registry record
- NCT07104331 · updated May 26, 2026